Impel Neuropharma Inc
Biotechnology
Healthcare
IMPL
23.75 M shares
NASDAQ US
traded
09 Aug 2023
listed
yes
open
1.21
52 week high
10.12
high
1.38
52 week low
1.32
previous Close
1.35
P/E ratio
market cap
28.50 M
div yield
0
net profit margin
0.00 %
883.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top